Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 09 2022
Historique:
received: 11 08 2021
accepted: 09 09 2022
pubmed: 25 9 2022
medline: 28 9 2022
entrez: 24 9 2022
Statut: epublish

Résumé

Infections by multidrug-resistant Enterobacteriaceae (MRE) are life-threatening to patients. The intestinal microbiome protects against MRE colonization, but antibiotics cause collateral damage to commensals and open the way to colonization and subsequent infection. Despite the significance of this problem, the specific commensals and mechanisms that restrict MRE colonization remain largely unknown. Here, by performing a multi-omic prospective study of hospitalized patients combined with mice experiments, we find that Lactobacillus is key, though not sufficient, to restrict MRE gut colonization. Lactobacillus rhamnosus and murinus increase the levels of Clostridiales bacteria, which induces a hostile environment for MRE growth through increased butyrate levels and reduced nutrient sources. This mechanism of colonization resistance, an interaction between Lactobacillus spp. and Clostridiales involving cooperation between microbiota members, is conserved in mice and patients. These results stress the importance of exploiting microbiome interactions for developing effective probiotics that prevent infections in hospitalized patients.

Identifiants

pubmed: 36153315
doi: 10.1038/s41467-022-33313-w
pii: 10.1038/s41467-022-33313-w
pmc: PMC9509339
doi:

Substances chimiques

Anti-Bacterial Agents 0
Butyrates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5617

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137269
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Cell Host Microbe. 2020 Jan 8;27(1):79-92.e9
pubmed: 31901520
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Nat Microbiol. 2018 Nov;3(11):1274-1284
pubmed: 30356154
Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):148-56
pubmed: 18221171
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
BMC Bioinformatics. 2015 Apr 29;16:137
pubmed: 25924884
Arch Intern Med. 2011 Mar 28;171(6):491-4
pubmed: 21444840
Cell Host Microbe. 2018 Aug 8;24(2):296-307.e7
pubmed: 30057174
J Med Microbiol. 2015 Jul;64(7):676-681
pubmed: 25934549
Cell Host Microbe. 2017 May 10;21(5):592-602.e4
pubmed: 28494240
Front Microbiol. 2020 Jul 17;11:1422
pubmed: 32765433
J Nutr. 2011 May;141(5):883-9
pubmed: 21430242
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S62-9
pubmed: 16894517
Curr Microbiol. 2013 Oct;67(4):395-8
pubmed: 23689939
PLoS One. 2013;8(1):e53957
pubmed: 23349773
PLoS Pathog. 2020 Mar 24;16(3):e1008448
pubmed: 32208465
Appl Environ Microbiol. 2017 Mar 17;83(7):
pubmed: 28130303
J Clin Invest. 2010 Dec;120(12):4332-41
pubmed: 21099116
J Hyg (Lond). 1971 Sep;69(3):405-11
pubmed: 4999450
Science. 2017 Apr 21;356(6335):315-319
pubmed: 28428425
mSphere. 2021 Jun 30;6(3):e0050021
pubmed: 34160234
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Nat Microbiol. 2020 Apr;5(4):630-641
pubmed: 31959968
Int J Syst Evol Microbiol. 2020 Apr;70(4):2782-2858
pubmed: 32293557
Environ Microbiol. 2010 Jul;12(7):1889-98
pubmed: 20236171
Haematologica. 2019 Jul;104(7):1309-1321
pubmed: 31221786
Front Microbiol. 2017 Nov 07;8:2114
pubmed: 29163406
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W29-37
pubmed: 21593126
mSphere. 2020 Apr 29;5(2):
pubmed: 32350099
Sci Rep. 2021 Nov 10;11(1):21602
pubmed: 34759297
Infect Immun. 1989 Feb;57(2):559-65
pubmed: 2643576
Clin Microbiol Infect. 2020 Apr;26(4):456-462
pubmed: 31494254
Vet Res. 2018 Dec 20;49(1):123
pubmed: 30572930
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
Clin Infect Dis. 2021 Oct 20;73(8):1524-1527
pubmed: 33966076
J Exp Med. 2019 Jan 7;216(1):84-98
pubmed: 30563917
Cell. 2018 Sep 6;174(6):1406-1423.e16
pubmed: 30193113
Nucleic Acids Res. 2007;35(21):7188-96
pubmed: 17947321
Proteomes. 2019 Jan 08;7(1):
pubmed: 30626002
ISME J. 2016 Mar;10(3):742-50
pubmed: 26394008
BMC Microbiol. 2021 May 20;21(1):151
pubmed: 34016052
Microbiome. 2018 Mar 21;6(1):54
pubmed: 29562943
BMC Microbiol. 2011 Aug 03;11:177
pubmed: 21813005
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
PLoS One. 2009 Oct 09;4(10):e7401
pubmed: 19816594
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Infect Dis. 2019 May 30;68(12):2053-2059
pubmed: 30239622
Nat Microbiol. 2019 Apr;4(4):623-632
pubmed: 30718848
Appl Environ Microbiol. 2004 Oct;70(10):5810-7
pubmed: 15466518
Curr Biol. 2020 Mar 23;30(6):1049-1062.e7
pubmed: 32142697
Int J Antimicrob Agents. 2016 Sep;48(3):265-70
pubmed: 27451088
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
mBio. 2019 Mar 12;10(2):
pubmed: 30862751
Nature. 2016 Dec 8;540(7632):280-283
pubmed: 27798599
Nat Microbiol. 2020 Feb;5(2):304-313
pubmed: 31907407
Nature. 2015 Jan 8;517(7533):205-8
pubmed: 25337874
Int J Antimicrob Agents. 2019 Apr;53(4):435-441
pubmed: 30578963
Int J Med Microbiol. 2021 Apr;311(3):151484
pubmed: 33756190
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31767720
Infect Immun. 2012 Jan;80(1):62-73
pubmed: 22006564
Microbiome. 2019 Sep 13;7(1):130
pubmed: 31519223
N Engl J Med. 2000 Dec 28;343(26):1925-32
pubmed: 11136263
Cell Host Microbe. 2016 Apr 13;19(4):443-54
pubmed: 27078066
mSystems. 2017 Dec 5;2(6):
pubmed: 29238752
Sci Rep. 2020 Oct 28;10(1):18521
pubmed: 33116172
J Antimicrob Chemother. 2017 Jan;72(1):128-136
pubmed: 27707993
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Genome Biol Evol. 2014 Oct 13;6(10):2866-82
pubmed: 25313016
Cell. 2020 Jan 23;180(2):221-232
pubmed: 31978342
Science. 2017 Aug 11;357(6351):570-575
pubmed: 28798125
Nat Microbiol. 2020 Jan;5(1):116-125
pubmed: 31686025
Nucleic Acids Res. 2020 Jan 8;48(D1):D440-D444
pubmed: 31691833
Bioinformatics. 2011 Aug 15;27(16):2194-200
pubmed: 21700674

Auteurs

Ana Djukovic (A)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.
Computational and Systems Biology Program, Sloan-Kettering Institute, New York, NY, USA.

María José Garzón (MJ)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.

Cécile Canlet (C)

Toxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.

Vitor Cabral (V)

Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Rym Lalaoui (R)

Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Marc García-Garcerá (M)

Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.

Julia Rechenberger (J)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Marie Tremblay-Franco (M)

Toxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.

Iván Peñaranda (I)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.

Leonor Puchades-Carrasco (L)

Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Antonio Pineda-Lucena (A)

Drug Discovery Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Molecular Therapeutics Program, Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain.

Eva María González-Barberá (EM)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Miguel Salavert (M)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

José Luis López-Hontangas (JL)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Miguel Á Sanz (MÁ)

Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Jaime Sanz (J)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.
CIBERONC, Instituto Carlos III, Madrid, Spain.

Bernhard Kuster (B)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Jean-Marc Rolain (JM)

Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Laurent Debrauwer (L)

Toxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.

Karina B Xavier (KB)

Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Joao B Xavier (JB)

Computational and Systems Biology Program, Sloan-Kettering Institute, New York, NY, USA.

Carles Ubeda (C)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain. ubeda_carmor@gva.es.
Centers of Biomedical Research Network (CIBER) in Epidemiology and Public Health, Madrid, Spain. ubeda_carmor@gva.es.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH